Abstract
Visiongain have the pleasure of announcing the latest edition of their
industry leading report - The World OTC Pharmaceutical Market, 2008-2023. This
edition updates the world OTC market at present and predicts its sales
revenues and trends from 2008-2023, including drivers and restraints on the
market. Sources used include industrial databases, commercial and financial
news, published reports and policy documents, interviews and questionnaires.
Visiongain applied financial forecasting, qualitative analyses and the
assessment of unmet needs to provide a comprehensive market-based report with
detailed analysis and informed opinion. The report examines the worldwide OTC
market, breaking down present and forecasted sales revenues into leading
therapeutic categories and national markets. Visiongain also provides
forecasts for leading OTC brands.
In particular, this report concentrates on the following essential aspects of
the global OTC industry:
- Major therapeutic areas treated by OTC products
- Key industrial players in the OTC market
- Financial forecasts covering the period 2008-2023, including leading
brands, countries and therapeutic areas
- Geographical breakdown of the market
- Sales of the highest-selling OTC brands and other relevant information
- Coverage of prescription-only to OTC switching in the pharma industry
Why you should buy this report:
- To receive a comprehensive analysis of the prospects for the OTC industry
from 2008-2023, including sales by therapeutic area and country
- To discover predicted revenues, growth rates and other key metrics for OTC
pharmaceuticals from 2008-2023, including those of leading brands
- To discover possible future OTC switching candidates
- To determine the forces that influence the OTC market:
- Drivers and restraints on market
- Competition
- Strengths, weaknesses, opportunities and threats
Visiongain forecasts that OTC pharmaceutical sales will almost double from
2007 levels by 2023. In the period 2008-2023, the worldwide OTC market will
undergo a period of dynamic change. Increasingly aging populations and rising
incidence of lifestyle diseases, as well as the need to reduce healthcare
costs, will open up new therapeutic areas for OTC switching. Likewise, sales
of existing OTC products will rise. At the same time, changes in retail
patterns and new ways of advertising will open up access to OTC drugs to a
public better educated and more interested in self-medication than at any
previous time. Taking advantage of such opportunities will take considerable
skill in a crowded and competitive marketplace. Consequently, the commercial
prospects are very good for companies well placed to serve those growing
needs. In these difficult times for the global pharmaceutical industry, OTC
sales will become increasingly important, visiongain concludes.
Further unique benefits to you when you order this report:
- You can access your report online, wherever you are
- Full searchable report when you buy the company or corporate editions
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables
View Cart
